Attention-Deficit/Hyperactivity Disorder Medication Prescription Claims Among Privately Insured Women Aged 15–44 Years — United States, 2003–2015

Details

• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR)
• Personal Author:
  Anderson, Kayla N. ; Ailes, Elizabeth C. ; Danielson, Melissa ; Lind, Jennifer N. ; Farr, Sherry L. ; Broussard, Cheryl S. ; Tinker, Sarah C.
• Description:
  Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that affects individuals across the lifespan. ADHD medication use among pregnant women is increasing (1), but consensus about the safety of ADHD medication use during pregnancy is lacking. Given that nearly half of U.S. pregnancies are unintended (2), and early pregnancy is a critical period for fetal development, examining Trends in ADHD medication prescriptions among reproductive-aged women is important to quantify the population at risk for potential exposure. CDC used the Truven Health MarketScan Commercial Database* for the period 2003-2015 to estimate the percentage of women aged 15-44 years with private employer-sponsored insurance who filled prescriptions for ADHD medications each year. The percentage of reproductive-aged women who filled at least one ADHD medication prescription increased 344% from 2003 (0.9% of women) to 2015 (4.0% of women). In 2015, the most frequently filled medications were mixed amphetamine salts, lisdexamfetamine, and methylphenidate. Prescribing ADHD medications to reproductive-aged women is increasingly common; additional research on ADHD medication safety during pregnancy is warranted to inform women and their health care providers about any potential risks associated with ADHD medication exposure before and during pregnancy.
• Subjects:
  Adolescent Adult Attention Deficit Disorder With Hyperactivity Central Nervous System Stimulants Drug Prescriptions Female Full Report Health Benefit Plans, Employee Humans Insurance, Health Insurance Claim Reporting Pregnancy Private Sector Young Adult

  More +
• Source:
  MMWR Morbidity Mortal Weekly Rep. 67(2):66-70.
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• DOI:
  http://dx.doi.org/10.15585/mmwr.mm6702a3
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Pubmed ID:
  29346342
• Pubmed Central ID:
  PMC5772805
• Document Type:
  Journal Article
• Place as Subject:
  United States
• Pages in Document:
  5 pdf pages
• Volume:
  67
• Issue:
  2
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:5781c860cc3777ce211fd900db4933cd635107b170da66828e453b65536de2c3e56adaee7edf803e66d7599d0542f72221b22cbafc86e2f2f380586dfd02971a
• Download URL:
  https://stacks.cdc.gov/view/cdc/54345/cdc_54345_DS1.pdf
• File Type:
  [PDF - 127.04 KB ]